Table of Content



1. Research Scope & Methodology
1.1. Study Objectives
1.2. Scope Of Study
1.3. Methodology
1.4. Assumptions & Limitations

2. Executive Summary
2.1. Market Size & Estimates
2.2. Market Overview

3. Market Dynamics
3.1. Market Definition
3.2. Key Drivers
3.2.1. Increasing Demand For Blood And Other Blood Related Products Across The World
3.2.2. Surge In Geriatric Population Across The Globe
3.2.3. Rise In Blood Donations And Plasma Donations
3.2.4. Promising Government Regulations For Blood Screening
3.2.5. Progression In Blood Transfusion And Blood Screening Instruments
3.3. Key Restraints
3.3.1. High Cost Of Advanced Blood Collection Devices
3.3.2. Dearth Of Skilled Laboratory Professionals

4. Key Analytics
4.1. Key Investment Insights
4.2. Porter’S Five Force Analysis
4.2.1. Buyer Power
4.2.2. Supplier Power
4.2.3. Substitution
4.2.4. New Entrants
4.2.5. Industry Rivalry
4.3. Opportunity Matrix
4.4. Vendor Landscape
4.5. Impact Of Covid – Blood Market

5. Market By Product
5.1. Whole Blood Collection
5.1.1. Whole Blood Collection Systems
5.1.2. Whole Blood Collection Reagents
5.2. Source Plasma Collection
5.2.1. Source Plasma Collection Systems
5.2.2. Source Plasma Collection Reagents
5.3. Blood Therapeutics
5.3.1. Intravenous Immunoglobulin (Ivig)
5.3.2. Albumin
5.3.3. Hyperimmune
5.3.4. Factor Viii
5.3.5. Factor Ix
5.3.6. Other Blood Therapeutics
5.4. Blood Typing
5.4.1. Blood Typing Systems
5.4.2. Blood Typing Reagents
5.5. Blood Screening
5.5.1. Blood Screening Systems
5.5.2. Blood Screening Reagents
5.6. Blood Processing Equipment
5.6.1. Blood Processing Equipment Systems
5.6.2. Blood Processing Equipment Reagents

6. Market By End-User
6.1. Blood & Blood Component Banks
6.2. Diagnostic Laboratories
6.3. Ambulatory Surgical Centers
6.4. Hospitals
6.5. Other End-Users

7. Geographical Analysis
7.1. North America
7.1.1. United States
7.1.2. Canada

8. Company Profiles
8.1. Abbott Laboratories
8.2. Bio-Rad Laboratories Inc
8.3. Csl Limited (Csl Behring)
8.4. F Hoffmann-La Roche Ltd
8.5. Grifols International Sa
8.6. Haemonetics Corporation
8.7. Merck & Co Inc
8.8. Novo Nordisk A/S
8.9. Baxter International Inc
8.10. Becton Dickinson And Company
8.11. Fresenius Kabi Ag
8.12. Ortho Clinical Diagnostics
8.13. Terumo Corporation (Terumo Bct Inc)
8.14. Immucor Inc



List of Figures


Figure 1: Key Investment Insights
Figure 2: Porter’S Five Force Analysis
Figure 3: Opportunity Matrix
Figure 4: Vendor Landscape
Figure 5: North America Blood Market, Growth Potential, By Product, In 2019
Figure 6: North America Blood Market, By Whole Blood Collection, 2019-2028 (In $ Million)
Figure 7: North America Blood Market, Growth Potential, By Whole Blood Collection, In 2019
Figure 8: North America Blood Market, By Whole Blood Collection Systems, 2019-2028 (In $ Million)
Figure 9: North America Blood Market, By Whole Blood Collection Reagents, 2019-2028 (In $ Million)
Figure 10: North America Blood Market, By Source Plasma Collection, 2019-2028 (In $ Million)
Figure 11: North America Blood Market, Growth Potential, By Source Plasma Collection, In 2019
Figure 12: North America Blood Market, By Source Plasma Collection Systems, 2019-2028 (In $ Million)
Figure 13: North America Blood Market, By Source Plasma Collection Reagents, 2019-2028 (In $ Million)
Figure 14: North America Blood Market, By Blood Therapeutics, 2019-2028 (In $ Million)
Figure 15: North America Blood Market, Growth Potential, By Blood Therapeutics, In 2019
Figure 16: North America Blood Market, By Source Plasma Collection Systems, 2019-2028 (In $ Million)
Figure 17: North America Blood Market, By Albumin, 2019-2028 (In $ Million)
Figure 18: North America Blood Market, By Hyperimmune, 2019-2028 (In $ Million)
Figure 19: North America Blood Market, By Factor Viii, 2019-2028 (In $ Million)
Figure 20: North America Blood Market, By Factor Ix, 2019-2028 (In $ Million)
Figure 21: North America Blood Market, By Other Blood Therapeutics, 2019-2028 (In $ Million)
Figure 22: North America Blood Market, By Blood Typing, 2019-2028 (In $ Million)
Figure 23: North America Blood Market, Growth Potential, By Blood Typing, In 2019
Figure 24: North America Blood Market, By Blood Typing Systems, 2019-2028 (In $ Million)
Figure 25: North America Blood Market, By Blood Typing Reagents, 2019-2028 (In $ Million)
Figure 26: North America Blood Market, By Blood Screening, 2019-2028 (In $ Million)
Figure 27: North America Blood Market, Growth Potential, By Blood Screening, In 2019
Figure 28: North America Blood Market, By Blood Screening Systems, 2019-2028 (In $ Million)
Figure 29: North America Blood Market, By Blood Screening Reagents, 2019-2028 (In $ Million)
Figure 30: North America Blood Market, By Blood Processing Equipment, 2019-2028 (In $ Million)
Figure 31: North America Blood Market, Growth Potential, By Blood Processing Equipment, In 2019
Figure 32: North America Blood Market, By Blood Processing Equipment Systems, 2019-2028 (In $ Million)
Figure 33: North America Blood Market, By Blood Processing Equipment Reagents, 2019-2028 (In $ Million)
Figure 34: North America Blood Market, Growth Potential, By End-User, In 2019
Figure 35: North America Blood Market, By Blood & Blood Component Banks, 2019-2028 (In $ Million)
Figure 36: North America Blood Market, By Diagnostic Laboratories, 2019-2028 (In $ Million)
Figure 37: North America Blood Market, By Ambulatory Surgical Centers, 2019-2028 (In $ Million)
Figure 38: North America Blood Market, By Hospitals, 2019-2028 (In $ Million)
Figure 39: North America Blood Market, By Other End-Users, 2019-2028 (In $ Million)
Figure 40: North America Blood Market, Regional Outlook, 2019 & 2028 (In %)
Figure 41: United States Blood Market, 2019-2028 (In $ Million)
Figure 42: Canada Blood Market, 2019-2028 (In $ Million)


List of Tables


TABLE 1: MARKET SNAPSHOT – BLOOD
TABLE 2: NORTH AMERICA BLOOD MARKET, BY PRODUCT, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 3: NORTH AMERICA BLOOD MARKET, BY PRODUCT, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 4: NORTH AMERICA BLOOD MARKET, BY END-USER, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 5: NORTH AMERICA BLOOD MARKET, BY END-USER, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 6: NORTH AMERICA BLOOD MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 7: NORTH AMERICA BLOOD MARKET, BY COUNTRY, FORECAST YEARS, 2019-2028 (IN $ MILLION)